Criteria for patient release according to external dose rate and residual activity in patients treated with 131I-sodium iodide in Iran.

Ahmadi Jeshvaghane, N; Paydar, R; Fasaei, B; Pakneyat, A; Karamloo, A; Deevband, M R; Khosravi, H R

Ahmadi Jeshvaghane, N; Paydar, R; Fasaei, B; Pakneyat, A; Karamloo, A; Deevband, M R; Khosravi, H R.

Affiliation

Ahmadi Jeshvaghane N; National Radiation Protection Department, Iranian Nuclear Regulatory Authority, PO Box 14155-4494, Tehran, Iran. nahmadi_j@yahoo.com

Radiat Prot Dosimetry ; 147(1-2): 264-6, 2011 Sep.

Article in En | MEDLINE | ID: mdl-21757441

Subject(s)

Iodine Radioisotopes/therapeutic use; Patient Discharge; Radiation Protection/standards; Radioimmunotherapy; Radiotherapy Dosage; Thyroid Diseases/diagnostic imaging; Thyroid Diseases/radiotherapy; Humans; Iran; Radionuclide Imaging; Thyroid Diseases/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Discharge / Radiation Protection / Radiotherapy Dosage / Thyroid Diseases / Radioimmunotherapy / Iodine Radioisotopes Limits: Humans Country/Region as subject: Asia Language: En Journal: Radiat Prot Dosimetry Year: 2011 Type: Article Affiliation country: Iran

Fulltext

XML

PubMed Links

Search on Google